Why the study?
Cardiovascular risk factors and disease are prevalent in COVID-19 and tied to worse outcomes, but presenting to acute cardiovascular services declined, prompting review of therapeutic implications for interventional cardiologists.
COVID-19 is associated with specific cardiovascular complications, notably a higher coronary thrombus burden in patients presenting with acute coronary syndromes, which has important therapeutic implications for interventional cardiologists.
Answers are grounded in this paper and cite their sources.
Reduced acute CV presentations early in COVID-19 signal risks of delayed care; extends evidence on pandemic effects on service utilization.
Although COVID-19 is viewed primarily as a respiratory disease, cardiovascular risk factors and disease are prevalent among infected patients and are associated with worse outcomes. In addition, among multiple extra-pulmonary manifestations, there has been an increasing recognition of specific cardiovascular complications of COVID-19. Despite this, in the initial stages of the pandemic there was evidence of a reduction in patients presenting to acute cardiovascular services. In this masterclass review, with the aid of 2 exemplar cases, we will focus on the important therapeutic implications of COVID-19 for interventional cardiologists. We summarize the existing evidence base regarding the varied cardiovascular presentations seen in COVID-19 positive patients and the prognostic importance and potential mechanisms of acute myocardial injury in this setting. Importantly, through the use of a systematic review of the literature, we focus our discussion on the observed higher rates of coronary thrombus burden in patients with COVID-19 and acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Kelham et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: